National Medicines Policy 2.0: a vision for the future

Por McLachlan, Andrew J, Aslani, Parisa
Publicado no Aust Prescr (2020)

Physiologically Based Pharmacokinetic Model for Terbinafine in Rats and Humans

Por Hosseini-Yeganeh, Mahboubeh, McLachlan, Andrew J.
Publicado em 2002

Clinical importance of the CYP2C19*17 variant allele for voriconazole

Por Dolton, Michael J, McLachlan, Andrew J
Publicado em 2011

Reply to “What Types of Candida Infections Should Be Included When Evaluating Breakthrough Infections during Posaconazole Prophylaxis?”

Por Dolton, Michael J., McLachlan, Andrew J.
Publicado em 2013

Australian pharmacists’ perspectives on physician-assisted suicide (PAS): thematic analysis of semistructured interviews

Por Isaac, Sami, McLachlan, Andrew, Chaar, Betty
Publicado no BMJ Open (2019)

Clinical Pharmacology of Chemotherapy Agents in Older People with Cancer

Por He, Xiaoye, Clarke, Stephen J., McLachlan, Andrew J.
Publicado em 2011

A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation Study

Por Adiwidjaja, Jeffry, Boddy, Alan V., McLachlan, Andrew J.
Publicado no CPT Pharmacometrics Syst Pharmacol (2018)

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics

Por Adiwidjaja, Jeffry, Boddy, Alan V., McLachlan, Andrew J.
Publicado no Front Pharmacol (2020)

Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically‐based pharmaco...

Por Adiwidjaja, Jeffry, Boddy, Alan V., McLachlan, Andrew J.
Publicado no Br J Clin Pharmacol (2020)

Bioinformatic challenges for the next decade(s)

Por Eisenberg, David, Marcotte, Edward, McLachlan, Andrew D, Pellegrini, Matteo
Publicado em 2006

A Scoping Review of Peer-led Education in Patient Safety Training

Por Walpola, Ramesh L., McLachlan, Andrew J., Chen, Timothy F.
Publicado no Am J Pharm Educ (2018)

The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people

Por Todd, Adam, Jansen, Jesse, Colvin, Jim, McLachlan, Andrew J.
Publicado no BMC Geriatr (2018)

Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic

Por Ray, John E, Marriott, Debbie, Bloch, Mark T, McLachlan, Andrew J
Publicado em 2005

Adverse Selection? A Multi-Dimensional Profile of People Dispensed Opioid Analgesics for Persistent Non-Cancer Pain

Por Rogers, Kris D., Kemp, Anna, McLachlan, Andrew J., Blyth, Fiona
Publicado em 2013

Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis

Por Mekonnen, Alemayehu B, McLachlan, Andrew J, Brien, Jo-anne E
Publicado no BMJ Open (2016)

Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review

Por Sakeena, M. H. F., Bennett, Alexandra A., McLachlan, Andrew J.
Publicado no Antimicrob Resist Infect Control (2018)

The Need to Strengthen the Role of the Pharmacist in Sri Lanka: Perspectives

Por Sakeena, M.H.F., Bennett, Alexandra A., McLachlan, Andrew J.
Publicado no Pharmacy (Basel) (2019)

Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques

Por Sasongko, Lucy, Williams, Kenneth M, Day, Richard O, McLachlan, Andrew J
Publicado em 2003

Effect of simvastatin on cyclosporine unbound fraction and apparent blood clearance in heart transplant recipients

Por Akhlaghi, Fatemeh, McLachlan, Andrew J., Keogh, Anne M., Brown, Kenneth F.
Publicado em 1997

Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring

Por Dolton, Michael J., Ray, John E., Marriott, Deborah, McLachlan, Andrew J.
Publicado em 2012